Hamlet Biopharma
Focus: Hamlet Biopharma is a Swedish oncology-focused biotech company specializing in small molecule therapeutics for bladder cancer. The company operates at a pre-revenue stage with a diversified pipeline spanning oncology, gastroenterology, and regenerative medicine.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Hamlet Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Hamlet Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Opioid Analgesic Treatment
Chronic PainClinical Trials (1)
NCT03701672Identification of Predictive Markers of the Effects of Opioid Therapy in Patients With Chronic Pain.
N/AHelp build intelligence for Hamlet Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.